Reversed-Phase High Performance Liquid Chromatographic Determination of Nifedipine in Human Plasma
- 1 September 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 7 (3) , 321-323
- https://doi.org/10.1097/00007691-198507030-00016
Abstract
A reversed-phase high performance liquid chromatographic method is presented by which the Ca channel blocker, nifedipine (NFP), may be measured in human serum using 17-.alpha.-ethinylestradiol as an internal standard. A mobile phase of phosphate buffer (0.01 M, pH 6.1)/methanol/acetonitrile (20:35:45) passed through a .mu.Bondapak C-18 column at 1.0 ml/min produced symmetrical bands for nifedipine and interal standard. A rapid and simple chloroform extraction of NFP from 1 ml serum samples proved to be efficient and reproducible. Recovery over a concentration range of 5-100 ng/ml was 92.3 .+-. 5.1% (mean .+-. SD, n = 6). UV absorbance detection at 235 nm was sensitive to serum NFP concentrations of 5 ng/ml. Between-day coefficients of variation at 100 and 5 ng/ml were 4.0 and 11.4%, respectively (n = 10). Serum concentration data from NFP-treated subjects are presented.This publication has 3 references indexed in Scilit:
- Determination of nifedipine in serum or plasma by reversed-phase liquid chromatography.Clinical Chemistry, 1983
- Determination of nifedipine in plasma by high-performance liquid chromatography.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical ApplicationsAnnals of Internal Medicine, 1980